1
Vernon G Wong: Biodegradable ocular implants. Visionex, Bertram I Rowland, November 17, 1992: US05164188 (281 worldwide citation)

Encapsulated agents are employed for introduction into the suprachoroid of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.


2
Vernon G Wong: Biodegradable ocular implants. Visionex, Bertram I Rowland, March 5, 1991: US04997652 (265 worldwide citation)

Encapsulated drugs are employed for introduction into the chambers of the eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.


3
Vernon G Wong: Biodegradable ocular implants. Visionex, Bertram I Rowland, August 1, 1989: US04853224 (261 worldwide citation)

Microencapsulated drugs are employed for introduction into the chambers of the eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.


4
Nivaggioli Thierry, Shiah Jane Guo, Lin Qing: Biodegradable ocular implants with long-term release characteristics. Allergan, Nivaggioli Thierry, Shiah Jane Guo, Lin Qing, DONOVAN Stephen, November 24, 2005: WO/2005/110362 (55 worldwide citation)

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 30 days and one year, or longer.


5
Wong Vernon G: Composition comprising biodegradable ocular implants.. Wong Vernon G, June 28, 1989: EP0322319-A2 (33 worldwide citation)

Microencapsulated drugs are proposed for introduction into the chambers of the eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.


6
Burkstrand Michael J, Erickson Signe R, Chudzik Stephen J: Biodegradable ocular implants and methods for treating ocular conditions. Surmodics, Burkstrand Michael J, Erickson Signe R, Chudzik Stephen J, WEAVER Paul L, May 22, 2008: WO/2008/060359 (10 worldwide citation)

Biodegradable ocular implants are described. The ocular implants include a bioactive agent that can be released within the eye to treat an ocular condition or indication. The implants can be used for the administration of a bioactive agent over prolonged periods of time. In some aspects the implants ...


7
Thierry Nivaggioli, Jane Guo Shiah, Qing Lin: Extended release biodegradable ocular implants. Allergan, Jennifer C Cheng, Joel B German, Debra D Condino, April 1, 2014: US08685435 (7 worldwide citation)

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.


8
Nivaggioli Thierry, Shiah Jane Guo, Lin Qing: Biodegradable ocular implants with long-term release characteristics. Allergan, January 10, 2007: EP1740153-A1 (1 worldwide citation)

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 30 days and one year, or longer.


9
Thierry Nivaggioli, James Jane Guo Shiah, Qing Lin: Extended release biodegradable ocular implants. Allergan, Laura L Wine, December 18, 2018: US10154960

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.


10
Thierry Nivaggioli, Jane Guo Shiah, Qing Lin: Extended release biodegradable ocular implants. Allergan, Barbara C Potts, November 25, 2014: US08895049

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.